Nektar Therapeutics: Q1 Earnings Insights

Nektar Therapeutics NKTR reported its Q1 earnings results on Tuesday, May 9, 2023 at 04:15 PM.

Here's what investors need to know about the announcement.

Earnings

Nektar Therapeutics missed estimated earnings by 28.0%, reporting an EPS of $-0.32 versus an estimate of $-0.25.

Revenue was down $3.23 million from the same period last year.

Past Earnings Performance

Last quarter the company beat on EPS by $0.13 which was followed by a 9.42% increase in the share price the next day.

Here's a look at Nektar Therapeutics's past performance:

Quarter Q4 2022 Q3 2022 Q2 2022 Q1 2022
EPS Estimate -0.45 -0.45 -0.94 -0.68
EPS Actual -0.32 -0.31 -0.85 -0.49
Revenue Estimate 22.13M 22.61M 22.66M 24.38M
Revenue Actual 22.02M 23.62M 21.59M 24.82M

To track all earnings releases for Nektar Therapeutics visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Date
ticker
name
Actual EPS
EPS Surprise
Actual Rev
Rev Surprise
Posted In: EarningsBZI-Recaps
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!